Efficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course Treatment

Simple item page
dc.contributor.authorKoshkin, V. S.
dc.contributor.authorDanchaivijitr, P.
dc.contributor.authorBae, W. K.
dc.contributor.authorSemenov, A.
dc.contributor.authorOzyilkan, O.
dc.contributor.authorSu, Y-L.
dc.contributor.authorArranz Arija, J. A.
dc.contributor.authorTsujihata, M.
dc.contributor.authorBoegemann, M.
dc.contributor.authorHendriks, M. P.
dc.contributor.authorNeciosup Delgado, S. P.
dc.contributor.authorCheng, S.
dc.contributor.authorRosenbaum, E.
dc.contributor.authorLopez, K.
dc.contributor.authorBavle, A.
dc.contributor.authorLiu, C-C.
dc.contributor.authorImai, K.
dc.contributor.authorFurka, A.
dc.date.accessioned2024-05-17T11:49:42Z
dc.date.available2024-05-17T11:49:42Z
dc.date.issued2023
dc.identifier.eissn1569-8041en_US
dc.identifier.endpageS1211en_US
dc.identifier.issn0923-7534en_US
dc.identifier.issueSupplement 2en_US
dc.identifier.startpageS1211en_US
dc.identifier.urihttp://hdl.handle.net/11727/12119
dc.identifier.volume34en_US
dc.identifier.wos001087480203373en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.annonc.2023.09.1027en_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEfficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course Treatmenten_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine